دورية أكاديمية
Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia.
العنوان: | Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia. |
---|---|
المؤلفون: | Schonardie AP; Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Ciências Médicas, Porto Alegre, RS, Brazil., Beck E; Pontifícia Universidade Católica do Rio Grande do Sul, Faculdade de Medicina, Porto Alegre, RS, Brazil., Rigatto MH; Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Ciências Médicas, Porto Alegre, RS, Brazil; Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Departamento de Medicina Interna, Porto Alegre, RS, Brazil; Programa de Liderança Médica Jovem da Academia Nacional de Medicina, Rio de Janeiro, RJ, Brazil; Infectious Disease Service, Hospital de Clínicas de Porto Alegre, RS, Brazil. Electronic address: mrigatto@hcpa.edu.br. |
المصدر: | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases [Braz J Infect Dis] 2023 Mar-Apr; Vol. 27 (2), pp. 102758. Date of Electronic Publication: 2023 Feb 18. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Editora Country of Publication: Brazil NLM ID: 9812937 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1678-4391 (Electronic) Linking ISSN: 14138670 NLM ISO Abbreviation: Braz J Infect Dis Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2010- : Rio de Janeiro : Elsevier Editora Original Publication: Salvador, Bahia, Brazil : Contexto, c1997- |
مواضيع طبية MeSH: | Bacteremia*/microbiology , Gram-Negative Bacterial Infections*/drug therapy , Gram-Negative Bacterial Infections*/epidemiology , Gram-Negative Bacterial Infections*/microbiology , Sepsis* , Hematologic Neoplasms*/complications , Febrile Neutropenia*/drug therapy, Humans ; Adolescent ; Adult ; Carbapenems/pharmacology ; Carbapenems/therapeutic use ; Prevalence ; Retrospective Studies ; Gram-Negative Bacteria ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use |
مستخلص: | Background: Carbapenem-Resistant Gram-Negative (CRGN) Bloodstream Infections (BSI) represent a therapeutic challenge, especially in the context of Febrile Neutropenia (FN) in cancer patients. Methods: We characterized pathogens causing BSI in patients aged ≥18 years who had undergone systemic chemotherapy for solid or hematological cancers between 2012 and 2021 in Porto Alegre, Brazil. Predictors of CRGN were evaluated through a case-control analysis. Each case was matched to two controls from whom CRGN were not isolated and had the same sex and year of inclusion in the study. Results: From 6094 blood cultures evaluated, 1512 (24.8%) showed positive results. Gram-negative bacteria accounted for 537 (35.5%) of the isolated bacteria, of which 93 (17.3%) were carbapenem-resistant. From 105 patients included in the case-control analysis, all cases had baseline hematological malignancies (60% acute myeloid leukemia). Variables related to CRGN BSI in Cox regression analysis were the first chemotherapy session (p<0.01), chemotherapy performed in the hospital setting (p = 0.03), intensive care unit admission (p<0.01), and CRGN isolation in the previous year (p<0.01). Patients with CRGN BSI received 75% less empirical active antibiotics and had 27.2% higher 30-day mortality rates than controls. Conclusions: A CRGN risk-guided approach should be considered for empirical antibiotic therapy in patients with FN. Competing Interests: Conflicts of interest None. (Copyright © 2023 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U. All rights reserved.) |
فهرسة مساهمة: | Keywords: Bloodstream infection; Carbapenem-resistance; Febrile neutropenia; Gram-negative infections |
المشرفين على المادة: | 0 (Carbapenems) 0 (Anti-Bacterial Agents) |
تواريخ الأحداث: | Date Created: 20230222 Date Completed: 20230328 Latest Revision: 20230328 |
رمز التحديث: | 20231215 |
مُعرف محوري في PubMed: | PMC10024133 |
DOI: | 10.1016/j.bjid.2023.102758 |
PMID: | 36809849 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1678-4391 |
---|---|
DOI: | 10.1016/j.bjid.2023.102758 |